Efficacy and Safety of GEN-001 (Lactococcus Lactis) Plus Total Neoadjuvant Therapy and Dynamic Change of Gut Microbiome in Locally Advanced Rectal Cancer : Exploratory, Pilot, Prospective, Longitudinal Study
Latest Information Update: 05 Feb 2024
At a glance
- Drugs Fluorouracil (Primary) ; Folinic acid (Primary) ; GEN 001 (Primary) ; Oxaliplatin (Primary)
- Indications Rectal cancer
- Focus Biomarker; Pharmacodynamics
- 20 Oct 2021 New trial record